Vecuronium Bromide for Injection Recalled for Manufacturing Temperature Deviation
McKesson Medical-Surgical is recalling Vecuronium Bromide for Injection (10 mg) manufactured by Teva Pharma USA due to cGMP deviations involving temperature abuse during production. The product was distributed nationwide; no illnesses have been reported.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II designation indicates potential for adverse consequences. Manufacturing deviations involving temperature abuse during drug production could compromise medication quality and integrity. No illnesses or adverse events reported to date.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Vecuronium Bromide for Injection, 10 mg (1 mg/mL), in 10-vial boxes, manufactured by Teva Pharma USA. The FDA identified Current Good Manufacturing Practice (cGMP) deviations during the manufacturing process.
The deviations involve temperature abuse during production. Temperature control issues during drug manufacturing can affect the quality and stability of the medication.
The recall affects approximately 20 cartons, each containing 10 vials, distributed nationwide. McKesson Medical-Surgical has stated it cannot identify specific lot numbers for individual customers; however, each customer letter includes the distribution date and the dates when affected product may have been shipped to that customer.
No illnesses or adverse events have been reported in connection with this recall. Healthcare providers and patients who have received this product should contact McKesson Medical-Surgical or their pharmaceutical supplier for guidance.
The recalled product
- Product
- Vecuronium Bromide for Injection, 10 mg (1mg/ mL) vial, 10-count box, Rx only, MFG: Teva Pharma USA, NDC 0703-2914-03
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Injectable
- Hazard
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature abuse
See all →- SevereKayem Foods Recalls Ready-to-Eat Meat and Poultry Due to Temperature Abuse
USDA FSIS · 2026-10-17
- ModerateZoladex Goserelin Implant Recalled Due to Temperature Abuse
FDA (Drugs) · 2026-10-07
- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
Similar recalls
- SevereTeva Recalls Vecuronium Bromide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-03-03
- SevereTeva Vecuronium Bromide Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-08-25
- HighFDA Recalls Rocuronium Bromide Injections Due to Improper Storage
FDA (Drugs) · 2024-03-20
- SevereSagent Recalls Vecuronium Bromide Injection Due to Manufacturing Deviations
FDA (Drugs) · 2013-06-26
- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- SevereTeva Recalls Amikacin Sulfate Injection Due to Manufacturing Deviations
FDA (Drugs) · 2016-10-19